PSDV


pSivida Corp. (PSDVׂ) Shares Climb 10% – Here’s Why

pSivida Corp. (NASDAQ:PSDV) investors are excited today after the drug maker announced it has entered a collaboration agreement with Nicox S.

Monday Morning’s Market Insights: Fitbit Inc (FIT), Valeant Pharmaceuticals Intl Inc (VRX), Chimerix Inc (CMRX), pSivida Corp. (PSDV)

Fitbit Inc (NYSE:FIT) is up 6% in pre-market trading this morning following Christmas Day’s news that its app made it to the top …

Tuesday’s Mid-Day Movers: pSivida Corp. (PSDV), Argos Therapeutics Inc (ARGS), Acacia Research Corp (ACTG), ORBCOMM Inc (ORBC)

pSivida Corp. (NASDAQ:PSDV) is soaring 32% at mid-day following positive late stage results from treatment Medidur.

pSivida Corp. (PSDV) Stock: Climbing On Solid Data

pSivida Corp. (NASDAQ:PSDV) is having an incredible day in the market today after posting solid data from a recent Phase 3 clinical trial.

Company Update (NASDAQ:PSDV): pSivida Corp. CEO to Speak at Controlled Release Society Annual Meeting Workshop in Edinburgh, Scotland, This Weekend

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced Dr.

Stock Update (NASDAQ:PSDV): pSivida Corp. Announces Positive Top Line Results From Investigator-Sponsored Phase II Study of Medidur™ for Uveitis

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced positive top line results …

Company Update (NASDAQ:PSDV): pSivida Corp. Announces Top-Line Results from Investigator-Sponsored Phase II Study of Medidur™ for Uveitis to Be Reported Next Week

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced that top line results from …

Stock Update (NASDAQ:PSDV): pSivida Corp. CEO to Present at ISOPT Clinical Meeting in Berlin in July 2015

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced Dr.

Stock Update (NASDAQ:PSDV): pSivida Corp. Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced positive safety data from …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts